Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants-Reference-Cited by-同舟云学术

Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants

Published:2022-10-26 Issue:5 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Cheng Hoi Lok¹,Lim Sing Mei¹,Jia Huan¹,Chen Ming Wei²,Ng Say Yong¹,Gao Xiaohong²,Somani Jyoti³,Sengupta Sharmila³,Tay Dousabel M. Y.⁴,Chua Patrina W. L.¹,R. Abirami¹,Ling Sharon Y. H.¹,McBee Megan E.¹,Young Barnaby E.⁵⁶⁷,Sikes Hadley D.¹⁴,Preiser Peter R.²^ORCID

Affiliation:

1. Singapore-MIT Alliance in Research and Technology, Singapore

2. School of Biological Sciences, Nanyang Technological University, Singapore

3. National University Hospital, Singapore, Singapore

4. Department of Chemical Engineering, Massachusetts Institute of Technology, USA

5. National Centre for Infectious Diseases, Singapore, Singapore

6. Tan Tock Seng Hospital, Singapore, Singapore

7. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

Abstract

Vaccination against SARS-CoV-2 induces protection through production of neutralization antibodies (nAb). The level of nAb is a major indicator of immunity against SARS-CoV-2 infection.

Funder

National Health Innovation Center

National Research Foundation Singapore

MOH | National Medical Research Council

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02257-22

Reference33 articles.

1. High-Resolution Temporal Response Patterns to Influenza Vaccine Reveal a Distinct Human Plasma Cell Gene Signature

2. Correlation of Vaccine Responses

3. Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.

4. Ministry of Health clinical practice guidelines: chronic hepatitis B infection;Chow WC;Singapore Med J,2011

5. Australian Government. n.d. Non-responders to hepatitis B vaccine are recommended to receive further doses and serological testing. The Australian Immunisation Handbook. https://immunisationhandbook.health.gov.au/recommendations/non-responders-to-hepatitis-b-vaccine-are-recommended-to-receive-further-doses-and-serological-testing. (accessed July 25 2022).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia;Viruses;2023-03-25

2. Development of a cellulose-based 96-well plate vertical flow pull-down assay;Analytical Methods;2023

3. Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era;Environment International;2023-01